The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
TH Karlsen, N Sheron, S Zelber-Sagi, P Carrieri… - The Lancet, 2022 - thelancet.com
Liver diseases have become a major health threat across Europe, and the face of European
hepatology is changing due to the cure of viral hepatitis C and the control of chronic viral …
hepatology is changing due to the cure of viral hepatitis C and the control of chronic viral …
[HTML][HTML] The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?
…, HE Mark, M Villota-Rivas, A Palayew, P Carrieri… - Journal of …, 2022 - Elsevier
Background & Aims Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent, yet largely
underappreciated liver condition which is closely associated with obesity and metabolic …
underappreciated liver condition which is closely associated with obesity and metabolic …
[HTML][HTML] Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV
…, S Buchbinder, C Caceres, PE Cahn, P Carrieri… - Nature …, 2021 - nature.com
Health systems have improved their abilities to identify, diagnose, treat and, increasingly,
achieve viral suppression among people living with HIV (PLHIV). Despite these advances, a …
achieve viral suppression among people living with HIV (PLHIV). Despite these advances, a …
[HTML][HTML] Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii
…, M Henry, F Armougom, H Richet, P Carrieri… - International journal of …, 2012 - nature.com
Background: Obesity is associated with increased health risk and has been associated with
alterations in bacterial gut microbiota, with mainly a reduction in Bacteroidetes, but few data …
alterations in bacterial gut microbiota, with mainly a reduction in Bacteroidetes, but few data …
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.
M Olivier, A Langer√∏ d, P Carrieri, J Bergh… - Clinical cancer research …, 2006 - AACR
To investigate the clinical value of somatic TP53 mutations in breast cancer, we assembled
clinical and molecular data on 1,794 women with primary breast cancer with long-term follow-…
clinical and molecular data on 1,794 women with primary breast cancer with long-term follow-…
Leptin increase in multiple sclerosis associates with reduced number of CD4+CD25+ regulatory T cells
G Matarese, PB Carrieri, A La Cava… - Proceedings of the …, 2005 - National Acad Sciences
We analyzed the serum and cerebrospinal fluid (CSF) leptin secretion and the interaction
between serum leptin and CD4 + CD25 + regulatory T cells (T Regs ) in naïve-to-therapy …
between serum leptin and CD4 + CD25 + regulatory T cells (T Regs ) in naïve-to-therapy …
Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants
…, C Procaccini, C La Rocca, PB Carrieri… - Nature …, 2015 - nature.com
… P < 0.05 and **P < 0.0001 (paired two-tailed Student's t-test (b) or Wilcoxon matched-pairs
test (d… For all analyses, we used two-sided tests, with a P value of <0.05 indicative of statistical …
test (d… For all analyses, we used two-sided tests, with a P value of <0.05 indicative of statistical …
Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy
…, M Savès, B Spire, V Cailleton, A Sobel, P Carrieri… - Aids, 2001 - journals.lww.com
… Even after multiple adjustment by logistic regression for other variables related to adherence
failure at M20 in univariate analysis (P ≤ 0.25), number of self-reported lipodystrophy-…
failure at M20 in univariate analysis (P ≤ 0.25), number of self-reported lipodystrophy-…
Regulatory T cell proliferative potential is impaired in human autoimmune disease
… We measured the levels of phosphorylated STAT5 (p-STAT5) upon CD3 and CD28 … We
found reduced activation of STAT5 (as assessed by the amount of p-STAT5) in T reg cells from …
found reduced activation of STAT5 (as assessed by the amount of p-STAT5) in T reg cells from …
The dynamic of adherence to highly active antiretroviral therapy: results from the French National APROCO cohort
P Carrieri, V Cailleton, V Le Moing… - JAIDS Journal of …, 2001 - journals.lww.com
Objectives: Our objective was to describe the evolution of adherence to highly active
antiretroviral therapy (HAART) over a 20-month period and its relationship with virologic success. …
antiretroviral therapy (HAART) over a 20-month period and its relationship with virologic success. …